ARTICLE
Ingenuous interpretation of elevated blood levels of macromolecular markers of myocardial injury: a recipe for confusion
Burton E. Sobel, MD, FACCa and
Martin M. LeWinter, MD, FACCa
a Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont, USA
Manuscript received July 30, 1999;
revised manuscript received October 27, 1999,
accepted December 15, 1999.
Reprint requests and correspondence: Dr. Burton E. Sobel, Department of Medicine, University of Vermont, Colchester Research Facility, 55A S. Park Drive, Colchester, Vermont 05446 burton.sobel{at}vtmednet.org
Several assumptions about elevations of macromolecular markers of myocardial injury in blood require critical consideration. The dichotomy of modest, persistent elevations of troponins I and T as prognostic factors in patients with unstable angina and absent elevations of isoenzymes of creatine kinase is presently unexplained. Factors influencing the appearance of macromolecular markers of myocardial injury in blood are considered, including the need to estimate baseline values, to consider elevations as deviations from baseline rather than simply points within a distribution of baseline values in normal subjects, to recognize operative biochemical and physiologic determinants of marker release from injured myocytes and washout and to take into account the influence of apoptosis. Elucidation and consideration of mechanisms underlying the appearance of specific macromolecular markers in blood appear likely to improve diagnosis and explain the prognostic power of the troponins in patients with unstable angina. Detection of proteolytic breakdown products of troponins in blood is likely to explain the modest, persistent elevations seen in some patients with unstable angina and their prognostic implications.
|
Abbreviations and Acronyms
| | AMI | = acute myocardial infarction | | CK | = creatine kinase | | HBD | = hydroxybutyric acid dehydrogenase | | LDH | = lactate dehydrogenase | | MB | = myocardial band | | MI | = myocardial infarction | | TnC | = troponin C | | TnI | = troponin I | | TnT | = troponin T |
|
This article has been cited by other articles:

|
 |

|
 |
 
S. SENTER and G. S. FRANCIS
A new, precise definition of acute myocardial infarction
Cleveland Clinic Journal of Medicine,
March 1, 2009;
76(3):
159 - 166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Giannitsis, H. Steen, K. Kurz, B. Ivandic, A. C. Simon, S. Futterer, C. Schild, P. Isfort, A. S. Jaffe, and H. A. Katus
Cardiac Magnetic Resonance Imaging Study for Quantification of Infarct Size Comparing Directly Serial Versus Single Time-Point Measurements of Cardiac Troponin T
J. Am. Coll. Cardiol.,
January 22, 2008;
51(3):
307 - 314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Wang
Significance of Circulating Troponins in Heart Failure: If These Walls Could Talk
Circulation,
September 11, 2007;
116(11):
1217 - 1220.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Latini, S. Masson, I. S. Anand, E. Missov, M. Carlson, T. Vago, L. Angelici, S. Barlera, G. Parrinello, A. P. Maggioni, et al.
Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure
Circulation,
September 11, 2007;
116(11):
1242 - 1249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Gibbons, U. S. Valeti, P. A. Araoz, and A. S. Jaffe
The quantification of infarct size
J. Am. Coll. Cardiol.,
October 19, 2004;
44(8):
1533 - 1542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Gami, A. Svatikova, R. Wolk, E. J. Olson, C. J. Duenwald, A. S. Jaffe, and V. K. Somers
Cardiac Troponin T in Obstructive Sleep Apnea
Chest,
June 1, 2004;
125(6):
2097 - 2100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. V. Luepker, F. S. Apple, R. H. Christenson, R. S. Crow, S. P. Fortmann, D. Goff, R. J. Goldberg, M. M. Hand, A. S. Jaffe, D. G. Julian, et al.
Case Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies: A Statement From the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute
Circulation,
November 18, 2003;
108(20):
2543 - 2549.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Freda, W. H. W. Tang, F. Van Lente, W. F. Peacock, and G. S. Francis
Cardiac troponins in renal insufficiency: Review and clinical implications
J. Am. Coll. Cardiol.,
December 18, 2002;
40(12):
2065 - 2071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Hovels-Gurich, J. F. Vazquez-Jimenez, A. Silvestri, K. Schumacher, R. Minkenberg, J. Duchateau, B. J. Messmer, G. von Bernuth, and M.-C. Seghaye
Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of the great arteries
J. Thorac. Cardiovasc. Surg.,
October 1, 2002;
124(4):
811 - 820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. van der Laarse
Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure
Cardiovasc Res,
October 1, 2002;
56(1):
8 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Vazquez-Jimenez, M. Qing, B. Hermanns, B. Klosterhalfen, M. Woltje, R. Chakupurakal, K. Schumacher, B. J. Messmer, G.o. von Bernuth, and M.-C. Seghaye
Moderate hypothermia during cardiopulmonary bypass reduces myocardial cell damage and myocardial cell death related to cardiac surgery
J. Am. Coll. Cardiol.,
October 1, 2001;
38(4):
1216 - 1223.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|